Heat can treat: long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients
Radiofrequency thermal ablation (RFA) for adenomyosis significantly reduced pain and abnormal uterine bleeding symptoms long-term, avoiding hysterectomy in most patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This single-center retrospective cohort study evaluated laparoscopic radiofrequency thermal ablation (RFA) as a uterine-sparing alternative to hysterectomy in 60 hysterectomy-candidate patients with symptomatic adenomyosis, with follow-up averaged 56 months (range 10–115) and pain assessed by pre/post ten-point visual analog scales. Concomitant endometriosis surgery occurred in 65% of patients, and hysterectomy was ultimately performed in 13% during follow-up; all measured pain components (dysmenorrhea, dyschezia, dyspareunia, and chronic pelvic pain) showed significant reductions after RFA, while bulk symptoms resolved in all affected patients and abnormal uterine bleeding persisted in 16% of those with baseline AUB. The paper explicitly cautions that it is retrospective and single-center, and it does not report a randomized comparison to other treatments. Relevance to endometriosis: the cohort includes 39/60 patients who had concomitant endometriosis surgery and the study was performed in a referral center for endometriosis, though the main focus is adenomyosis and hysterectomy avoidance via RFA. This paper is centrally about adenomyosis — it reports long-term symptom and hysterectomy outcomes after RFA uterine-sparing treatment.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
9,022 characters
· extracted from
oa-doi-fallback
· 6 sections
· click to expand
Abstract
Methods
Results
Conclusions
References
Acknowledgements
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis via openalex
- How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex
- Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis via openalex
- Laparoscopic Radiofrequency Thermal Ablation for Uterine Adenomyosis via openalex
- Nerve-sparing laparoscopic eradication of deep endometriosis with segmental rectal and parametrial resection: the Negrar method. A single-center, prospective, clinical trial via openalex
- New paradigms in the conservative surgical and interventional management of adenomyosis via openalex
- Pathophysiology of adenomyosis via openalex
- Pregnancy and symptomatic relief following ultrasound‐guided transvaginal radiofrequency ablation in patients with adenomyosis via openalex
- Sonographic classification and reporting system for diagnosing adenomyosis via openalex
- Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group via openalex
- The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study via openalex
- Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: A single center experience from the Republic of Korea via openalex
- Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- Uterine artery embolisation in women with symptomatic adenomyosis via openalex
- W2761476075 via openalex
- W2096998881 via openalex
- W2063086232 via openalex
- W2971743895 via openalex
- W1992596353 via openalex
- W2989384704 via openalex
- W2515052691 via openalex
- W1965039757 via openalex
- W2546672984 via openalex
- W2340949707 via openalex
Cited by (8)
- Artificial intelligence and modern surgical energy-based technologies in the treatment of women of reproductive age with adenomyosis and uterine fibroids (literature review and own data) 2026
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society 2025
- Correlation between sonographic classification and the efficacy of microwave ablation for adenomyosis 2024
- Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal 2024
- Alternative treatments of adenomyosis - an update in procedural management and clinical outcomes 2024
- Treatment of adenomyosis, abdominal wall endometriosis and uterine leiomyoma with interventional radiology: A review of current evidences 2023
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Radiofrequency Ablation for Adenomyosis 2023
Source provenance
- europepmc
- last seen: 2026-08-22T06:09:51.966504+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00